Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levels

Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia

(2016) Antoine Rimbert et al.   ATHEROSCLEROSIS

Update on the molecular biology of dyslipidemias

(2016) I. Ramasamy   CLINICA CHIMICA ACTA

Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B

(2016) Berna Seker Yilmaz et al.   CLINICA CHIMICA ACTA

The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population

(2016) Moon Hee Yang et al.   Journal of Clinical Lipidology

Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia

(2016) Naotaka Ohta et al.   Journal of Clinical Lipidology

PCSK9 levels in abdominally obese men: Association with cardiometabolic risk profile and effects of a one-year lifestyle modification program

(2014) Benoit J. Arsenault et al.   ATHEROSCLEROSIS

Update on Primary Hypobetalipoproteinemia

(2014) Amanda J. Hooper et al.   Current Atherosclerosis Reports

Hypobetalipoproteinemia and abetalipoproteinemia

(2014) Francine K. Welty   CURRENT OPINION IN LIPIDOLOGY

Western Database of Lipid Variants (WDLV): A Catalogue of Genetic Variants in Monogenic Dyslipidemias

(2013) Jennifer Fu et al.   CANADIAN JOURNAL OF CARDIOLOGY

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations

(2013) Janice Mayne et al.   Lipids in Health and Disease

Genetic variation inAPOB,PCSK9, andANGPTL3in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels

(2011) Roeland Huijgen et al.   HUMAN MUTATION

Association of Lipid and Lipoprotein Profiles with Future Development of Type 2 Diabetes in Nondiabetic Korean Subjects: A 4-Year Retrospective, Longitudinal Study

(2011) Mi Hae Seo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

PCSK9R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease

(2010) Marianne Benn et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease

(2009) Marianne Abifadel et al.   HUMAN MUTATION

Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia

(2008) Shoji Katsuda et al.   CLINICA CHIMICA ACTA

Genetic variants in PCSK9 in the Japanese population: Rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population

(2007) Yasuko Miyake et al.   ATHEROSCLEROSIS